Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

19 Jul 2006 07:59

Investec Bank (UK) Limited19 July 2006 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in INTERSERVE PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 10,205 360.0 p 357.44 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in ENODIS PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) 25,000 215.0 p 215.0 p (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected ENODIS PLCNature of connection (Note 6) JOINT BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader INVESTEC BANK (UK) LTDCompany dealt in MACLELLAN GROUP PLCClass of relevant security to which the ORDINARY SHARESdealings being disclosed relate (Note 1) Date of dealing 18/07/2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) Lowest price paid (Note 3) 12,329 113.0 p 112.0 p Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3) (b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of securities Exercise Type, e.g. Expiry Option money purchasing, to which the option American,e.g. call option varying etc. relates (Note 5) price European etc. date paid/received per unit (Note 3) (ii) Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 19/07/2006 Contact name GARY DARCH Telephone number 020 7597 4549 Name of offeree/offeror with which connected MACLELLAN GROUP PLCNature of connection (Note 6) ADVISER & BROKER Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jun 20179:20 amRNSHolding(s) in Company
20th Jun 20173:51 pmRNSHolding(s) in Company
20th Jun 20177:00 amRNSInterserve announces contract win
19th Jun 201712:24 pmRNSHolding(s) in Company
14th Jun 20174:04 pmRNSHolding(s) in Company
14th Jun 20171:55 pmRNSHolding(s) in Company
13th Jun 201711:00 amRNSHolding(s) in Company
9th Jun 20172:19 pmRNSDirector/PDMR Shareholding
12th May 20173:04 pmRNSResult of AGM
12th May 20177:00 amRNSAGM Trading Update
9th May 20173:45 pmRNSDirector/PDMR Shareholding
24th Apr 201712:45 pmRNSHolding(s) in Company
24th Apr 20177:00 amRNSInterserve wins £36.5 million contract
18th Apr 20173:08 pmRNSDirector/PDMR Shareholding - Correction
12th Apr 20172:34 pmRNSDirector/PDMR Shareholding
7th Apr 201711:49 amRNSDirector/PDMR Shareholding
30th Mar 20179:01 amRNSPublication of Annual Report 2016
22nd Mar 20179:49 amRNSHolding(s) in Company
14th Mar 20178:44 amRNSHolding(s) in Company
10th Mar 201710:00 amRNSDirector/PDMR Shareholding
9th Mar 201712:27 pmRNSHolding(s) in Company
8th Mar 20179:12 amRNSDirector/PDMR Shareholding
7th Mar 20177:00 amRNSDebbie White appointed as Chief Executive Officer
6th Mar 20172:48 pmRNSHolding(s) in Company
6th Mar 20172:47 pmRNSHolding(s) in Company
3rd Mar 20179:27 amRNSHolding(s) in Company
28th Feb 20177:00 amRNSFinal Results
20th Feb 20177:00 amRNSEnergy from Waste Update
10th Feb 201711:29 amRNSDirector/PDMR Shareholding
6th Feb 20177:00 amRNSContract Win
11th Jan 20177:00 amRNSBoard Appointment
11th Jan 20177:00 amRNSTrading Update
10th Jan 20171:27 pmRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSBlock listing Interim Review
9th Dec 20163:20 pmRNSDirector/PDMR Shareholding
15th Nov 20161:00 pmRNSEnergy from Waste Update
14th Nov 20162:16 pmRNSTrading Update
14th Nov 20162:15 pmRNSBoard Change
14th Nov 20167:00 amRNSContract Win
9th Nov 201612:17 pmRNSDirector/PDMR Shareholding
31st Oct 201610:31 amRNSDirector/PDMR Shareholding
21st Oct 201611:18 amRNSHolding(s) in Company
19th Oct 20167:00 amRNSInterserve hosts capital markets day in London
17th Oct 20167:00 amRNSContract Win
12th Oct 201611:59 amRNSDirector/PDMR Shareholding
10th Oct 20167:00 amRNSConclusion of Strategic Review
3rd Oct 20167:00 amRNSContract Win
27th Sep 20167:00 amRNSPlace on department of health's £4BN P22 framework
21st Sep 20167:00 amRNSInterserve JV wins £81m UAE mall contract
19th Sep 20167:00 amRNS£11 million environment agency contract extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.